
Ra Medical Systems RMED
Annual report 2025
added 03-31-2026
Country |
|
IPO year |
2018 |
Industry |
Medical devices |
Stock Exchange |
NYSE AMERICAN |
Shares |
1.08 M |
Market Cap[1] |
$ 610 K |
EBITDA (LTM) |
$ -13.6 M |
P/E (LTM) |
- |
P/S (LTM) |
0.9 |
EPS (LTM) |
-40.61 |
Other stocks of industry "Medical devices"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
GenMark Diagnostics, Inc.
GNMK
|
- | - | $ 1.77 B | Nasdaq Global Select Market | ||
|
AdaptHealth Corp.
AHCO
|
$ 13.06 | 2.03 % | $ 1.77 B | Nasdaq Capital Market | ||
|
Allied Healthcare Products
AHPI
|
- | 3.58 % | $ 2.21 M | Nasdaq Capital Market | ||
|
BioSig Technologies
BSGM
|
- | 37.08 % | $ 85.7 M | Nasdaq Global Select Market | ||
|
Avinger
AVGR
|
- | -20.74 % | $ 369 K | Nasdaq Capital Market | ||
|
Lianluo Smart Limited
LLIT
|
- | 24.59 % | $ 44.8 M | Nasdaq Global Select Market | ||
|
Axonics Modulation Technologies
AXNX
|
- | - | $ 3.31 B | Nasdaq Global Select Market,SPB | ||
|
Aziyo Biologics
AZYO
|
- | 1.37 % | $ 20.5 M | Nasdaq Global Market | ||
|
BIOLASE
BIOL
|
- | -13.19 % | $ 166 K | Nasdaq Capital Market | ||
|
Obalon Therapeutics, Inc.
OBLN
|
- | -5.86 % | $ 30.6 M | Nasdaq Capital Market | ||
|
Conformis
CFMS
|
- | - | $ 16.4 M | Nasdaq Capital Market | ||
|
Cytosorbents Corporation
CTSO
|
$ 0.65 | 3.45 % | $ 40.5 M | Nasdaq Capital Market | ||
|
Apollo Endosurgery
APEN
|
- | - | $ 475 M | Nasdaq Global Market | ||
|
EDAP TMS S.A.
EDAP
|
$ 3.27 | 1.4 % | $ 122 M | Nasdaq Global Market | ||
|
Cardiovascular Systems
CSII
|
- | 0.15 % | $ 844 M | Nasdaq Global Select Market,SPB | ||
|
ClearPoint Neuro
CLPT
|
$ 11.21 | -4.84 % | $ 317 M | Nasdaq Capital Market | ||
|
Globus Medical
GMED
|
$ 93.81 | -1.13 % | $ 12.7 B | NYSE,SPB | ||
|
Dynatronics Corporation
DYNT
|
- | 14.99 % | $ 929 K | Nasdaq Capital Market | ||
|
Eargo
EAR
|
- | - | $ 10.2 M | Nasdaq Global Select Market,SPB | ||
|
Helius Medical Technologies
HSDT
|
$ 2.22 | 2.78 % | $ 1.35 M | Nasdaq Capital Market | ||
|
CryoLife, Inc.
CRY
|
- | -4.14 % | $ 702 M | NYSE,SPB | ||
|
Electromed
ELMD
|
$ 26.75 | 1.36 % | $ 226 M | NYSE American | ||
|
Second Sight Medical Products
EYES
|
- | -0.97 % | $ 54.4 M | Nasdaq Capital Market | ||
|
CHF Solutions, Inc.
CHFS
|
- | 1.15 % | $ 34.5 M | Nasdaq Capital Market | ||
|
GBS
GBS
|
- | -0.57 % | $ 7.12 M | Nasdaq Global Market | ||
|
Soliton, Inc.
SOLY
|
- | -1.42 % | $ 435 M | Nasdaq Global Select Market | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
- | -1.98 % | $ 98.3 M | Nasdaq Capital Market | ||
|
Itamar Medical Ltd.
ITMR
|
- | 0.03 % | $ 1.58 B | Nasdaq Global Select Market | ||
|
Misonix, Inc.
MSON
|
- | - | $ 462 M | Nasdaq Global Select Market | ||
|
Neovasc
NVCN
|
- | - | $ 111 M | Nasdaq Capital Market | ||
|
OrthoPediatrics Corp.
KIDS
|
$ 16.3 | 0.65 % | $ 382 M | Nasdaq Global Select Market,SPB | ||
|
LivaNova PLC
LIVN
|
$ 63.66 | -0.84 % | $ 3.47 B | Nasdaq Global Select Market | ||
|
LENSAR
LNSR
|
$ 5.14 | 1.02 % | $ 61.5 M | Nasdaq Capital Market | ||
|
Butterfly Network
BFLY
|
$ 5.43 | 1.69 % | $ 1.15 B | NYSE | ||
|
Intersect ENT, Inc.
XENT
|
- | - | $ 955 M | Nasdaq Global Market | ||
|
Pulmonx Corporation
LUNG
|
$ 1.27 | 0.39 % | $ 51.7 M | Nasdaq Global Select Market | ||
|
Delcath Systems
DCTH
|
$ 10.99 | 1.38 % | $ 394 M | Nasdaq Capital Market | ||
|
IRIDEX Corporation
IRIX
|
$ 1.1 | 3.3 % | $ 18.6 M | Nasdaq Global Select Market | ||
|
Insulet Corporation
PODD
|
$ 190.5 | 0.5 % | $ 13.4 B | Nasdaq Global Select Market,SPB | ||
|
CONMED Corporation
CNMD
|
$ 39.89 | 3.93 % | $ 1.24 B | NYSE,SPB | ||
|
Inspire Medical Systems
INSP
|
$ 55.34 | -1.65 % | $ 1.63 B | NYSE,SPB | ||
|
Integer Holdings Corporation
ITGR
|
$ 84.77 | -1.43 % | $ 2.94 B | NYSE,SPB | ||
|
PAVmed
PAVM
|
$ 8.72 | -3.11 % | $ 5.85 M | Nasdaq Capital Market | ||
|
Invacare Corporation
IVC
|
- | - | $ 24.7 M | NYSE | ||
|
Edwards Lifesciences Corporation
EW
|
$ 84.05 | -0.24 % | $ 49.2 B | NYSE,SPB | ||
|
Sintx Technologies
SINT
|
$ 2.56 | 3.64 % | $ 7.1 M | Nasdaq Capital Market | ||
|
MiMedx Group
MDXG
|
$ 3.43 | -0.15 % | $ 507 M | Nasdaq Global Select Market | ||
|
Stryker Corporation
SYK
|
$ 329.41 | 0.59 % | $ 126 B | NYSE,SPB | ||
|
Tactile Systems Technology
TCMD
|
$ 24.83 | -0.96 % | $ 568 M | Nasdaq Global Select Market,SPB | ||
|
Nevro Corp.
NVRO
|
- | - | $ 217 M | NYSE,SPB |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.